Pulmonary surfactant dysfunction and lung maturation in neonatal foals: Therapy, prevention, and prognosis

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 26, Issue 6, 2004, Pages 460-468

  Costa, Lais R R ^a   Eades, Susan C ^a   Goad, M Elizabeth ^b   Paradis, Mary Rose ^c  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b PFIZER INC   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 3142720355     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Costa LRR, Eades SC, Goad ME, Paradis MR: Pulmonary surfactant dysfunction in neonatal foals: Pathogenesis and clinical findings. Compend Contin Educ Pract Vet 26(5):380-389, 2004.
2. Will DH, McMurtry IF, Reeves JT, Grover RF: Cold-induced pulmonary hypertension in cattle. J Appl Physiol 45:469-473, 1978.
3. Beech J: Respiratory problems in foals. Compend Contin Educ Pract Vet 8:S284-S292, 1986.
4. Palmer J: Respiratory support of critical equine neonates. Proc ACVIM Forum:188-190, 2003.
5. Palmer JE: Ventilatory support of the neonatal foal. Vet Clin North Am Equine Pract 10:167-185, 1994.
6. Drummond WH, Sanchez IR, Kosch PC, Webb AI: Pulmonary vascular reactivity of the newborn pony foal. Equine Vet J 21:181-185, 1989.
7. Sassoon CS, McGovern JP: Oxygenation strategy, in Grenvik A, Ayres SM, Holbrook PR, Shoemaker WC (eds): Textbook of Critical Care, ed 4. Philadelphia, WB Saunders, 2000, pp 1308-1323.
8. Robertson B: Neonatal respiratory distress syndrome and surfactant therapy: A brief review. Eur Respir J Suppl 3:73S-76S, 1989.
9. Kresch MJ, Lin WH, Thrall RS: Surfactant replacement therapy. Thorax 51:1137-1154, 1996.
10. Mason RJ, Voelker DR: Regulatory mechanisms of surfactant secretion. Biochim Biophys Acta 1408:226-240, 1998.
11. Kinsella JP, Ivy DD, Abman SH: Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease. Pediatr Res 36:402-408, 1994.
12. Kinsella JP, Parker TA, Galan H, et al: Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 41:457-463, 1997.
13. Abman SH: Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension. Curr Opin Pediatr 6:239-247, 1994.
14. Christou H, Adatia I, Van Marter LJ, et al: Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5′-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. J Pediatr 130:603-611, 1997.
15. Lester GD, DeMarco VG, Norman WM: Effect on inhaled nitric oxide on experimentally induced pulmonary hypertension in neonatal foals. Am J Vet Res 60:1207-1212, 1999.
16. Lester G, DeMarco V: Inhaled nitric oxide in newborn foal. Proc Neonatal Septicemia Workshop 2, Dorothy R. Havemeyer Foundation:40, 1998.
17. Palmer JE: Use of inhaled nitric oxide in improving pulmonary gas exchange in persistent pulmonary hypertension and pulmonary failure secondary to septic shock in the neonatal foal and calf. Proc Neonatal Septicemia Workshop 2, Dorothy R. Havemeyer Foundation:41, 1998.
18. 2+ entry. Am J Physiol 270:LA69-474, 1996.
19. Skobeloff EM, Spivey WH, McNamara RM, Greenspon L: Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA 262:1210-1213, 1989.
20. Ciarallo L, Sauer AH, Shannon MW: Intravenous magnesium therapy for moderate to severe pediatric asthma: Results of a randomized, placebo, controlled trial. J Pediatrics 129:809-814, 1996.
21. Thordstein M, Bagenholm R, Thiringer K, Kjellmer I: Scavengers of free oxygen radicals in combination with magnesium ameliorate perinatal hypoxic-ischemic brain damage in the rat. Pediatr Res 34:23-26, 1993.
22. th Int Vet Emerg Crit Care Symp:661-664, 2002.
23. Kojima T, Hattori K, Hirata Y, et al: Endothelin-1 has a priming effect on production of superoxide anion by alveolar macrophages: Its possible correlation with bronchopulmonary dysplasia. Pediatr Res 39:112-116, 1996.
24. Rosenberg AA, Kennaugh J, Koppenhafer SL, et al: Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 123:109-114, 1993.
25. Kaapa P, Kero P, Ekbland H, et al: Plasma endothelin-1 in the neonatal respiratory distress syndrome. Ann Chir Gynaecol 208(Suppl):110-112, 1994.
26. Dobyns EL, Eells PL, Griebel JL, Abman SH: Elevated plasm endothelin-1 and cytokine levels in children with severe acute respiratory distress syndrome. J Pediatr 135:246-249, 1999.
27. Malamitsi-Puchner A, Economou E, Efstathopoulos T, et al: Endothelin 1-21 plasma concentrations on days 1 and 4 of life in healthy and ill preterm neonates. Biol Neonate 67:317-321, 1995.
28. Sanai L, Haynes WG, MacKenzie A, et al: Endothelin production in sepsis and the adult respiratory distress syndrome. Intensive Care Med 22:52-56, 1996.
29. Kuo CY, Chen JY: Effect of meconium aspiration on plasma endothelin-1 level and pulmonary hemodynamics in a piglet model. Biol Neonate 76:228-234, 1999.
30. Costa LRR, Eades SC, Moore RM: Unpublished data, Louisiana State University, Baton Rouge, 2003.
31. Costa LRR, Mirza MH, Williams J, et al: Acute respiratory distress in a foal [abstract]. Vet Pathol 37:534, 2000.
32. Caddell JL: Evidence for magnesium deficiency in pathogenesis of bronchopulmonary dysplasia. Magnesium Res 9:205-216, 1996.
33. Koterba AM, Paradis MR: Specific respiratory conditions, in Koterba AM, Drummond WH, Kosch P (eds): Equine Clinical Neonatology. Philadelphia, Lea & Febiger, 1990, pp 177-199.
34. Schofield D, Cotran RS: Diseases of infancy and childhood, in Cotran RS, Kumar V, Colline T (eds): Robbins: Pathologic Basis of Disease, ed 6. Philadelphia, WB Saunders, 1999, pp 459-491.
35. Peaker M, Rossdale PD, Forsynth IA, Falk M: Changes in mammary development and the composition of secretion during late pregnancy in the mare. J Reprod Fert Suppl 127:555-561, 1979.
36. DeLemos RA, Shermeta DW, Knelson JH, et al: Acceleration of appearance of pulmonary surfactant in the fetal lamb by administration of corticosteroids. Am Rev Respir Dis 102(3):459-461, 1970.
37. 2α analogue to their dams before parturition. Am J Vet Res 58:404-407, 1997.